XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net income (loss) $ 12,464 $ (9,068)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Loss on impairment 3 4,302
Depreciation 216 254
Amortization of intangible assets 929 1,528
Amortization of capitalized software development costs 281 248
Amortization of deferred financing costs 8 155
Gain on PPP loan forgiveness (10,127) 0
Stock-based compensation expense 784 357
Bad debt (recovery) expense (133) 103
Gain on derivative instruments, net 0 (35)
Deferred income taxes 0 57
Gain on sale of equipment 0 (5)
Changes in assets and liabilities:    
Contract receivables, net (1,888) 6,114
Prepaid expenses and other assets (5,356) 983
Accounts payable, accrued compensation and accrued expenses 1,409 (1,536)
Billings in excess of revenue earned (831) (1,195)
Accrued warranty (192) (285)
Other liabilities 2,147 (332)
Net cash (used in) provided by operating activities (286) 1,645
Cash flows from investing activities:    
Capital expenditures (392) (4)
Proceeds from sale of equipment 0 11
Capitalized software development costs (226) (250)
Net cash used in investing activities (618) (243)
Cash flows from financing activities:    
Proceeds from line of credit 800 4,200
Repayment of line of credit (1,739) (694)
Repayment of insurance premium (609) 0
Repayment of long-term debt 0 (18,480)
Proceeds from Paycheck Protection Program Loan 0 10,000
Interest rate swap 0 (209)
Shares withheld to pay taxes (188) (77)
Deferred financing costs 0 (80)
Net cash used in financing activities (1,736) (5,340)
Effect of exchange rate changes on cash (19) (93)
Net decrease in cash and cash equivalents (2,659) (4,031)
Cash, cash equivalents at beginning of the period 6,702 11,691
Cash and cash equivalents at the end of the period $ 4,043 $ 7,660